CO6150123A2 - Formulacion de aerosol que contiene derivados de benzoxazin-3onas - Google Patents
Formulacion de aerosol que contiene derivados de benzoxazin-3onasInfo
- Publication number
- CO6150123A2 CO6150123A2 CO09028166A CO09028166A CO6150123A2 CO 6150123 A2 CO6150123 A2 CO 6150123A2 CO 09028166 A CO09028166 A CO 09028166A CO 09028166 A CO09028166 A CO 09028166A CO 6150123 A2 CO6150123 A2 CO 6150123A2
- Authority
- CO
- Colombia
- Prior art keywords
- 4alkyl
- enantiomers
- alkyl
- halogen
- formulation containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1.- Formulación medicamentosa que contiene como principio activo uno o varios compuestos de la fórmula general 1en los queR1 significa hidrógeno, alquilo-C1-4, O-alquilo-C1-4 o halógeno; R2 significa hidrógeno, alquilo-C1-4, O-alquilo-C1-4 o halógeno; R3 significa hidrógeno, alquilo-C1-4, O-alquilo-C1-4-, halógeno, OH, -O-alquilen-C1-4-COOH u O-alquilen-C1-4-COO-alquilo-C1-4, X- significa un anión de carga negativa simple o múltiple, con preferencia un anión de carga negativa simple o múltiple seleccionado del grupo compuesto por cloruro, bromuro, yoduro, sulfato, fosfato, metansulfonato, nitrato, maleato, acetato, benzoato, citrato, salicilato, trifluoroacetato, fumarato, tartrato, oxalato, succinato, benzoato y p-toluensulfonato, eventualmente en forma de sus tautómeros, enantiómeros, mezclas de los enantiómeros, racematos, solvatos o hidratos; un principio activo 2 seleccionado del grupo consistente en budesonida, beclometasona, fluticasona, ciclesonida o un metabolito del mismo, eventualmente en forma de sus tautómeros, enantiómeros, mezclas de los enantiómeros, racematos, solvatos o hidratos; al menos un ácido farmacológicamente tolerable o un sistema tampón farmacológicamente tolerable, eventualmente otros coadyuvantes farmacológicamente tolerables, así como en calidad de disolvente agua, etanol o una mezcla de agua y etanol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06119129 | 2006-08-18 | ||
| EP07101128 | 2007-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6150123A2 true CO6150123A2 (es) | 2010-04-20 |
Family
ID=39082381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09028166A CO6150123A2 (es) | 2006-08-18 | 2009-03-18 | Formulacion de aerosol que contiene derivados de benzoxazin-3onas |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080041370A1 (es) |
| EP (1) | EP2054034A2 (es) |
| JP (1) | JP2010501021A (es) |
| KR (1) | KR20090040922A (es) |
| AR (1) | AR062424A1 (es) |
| AU (1) | AU2007285746A1 (es) |
| BR (1) | BRPI0715692A2 (es) |
| CA (1) | CA2660480A1 (es) |
| CO (1) | CO6150123A2 (es) |
| EA (1) | EA200900267A1 (es) |
| IL (1) | IL197024A0 (es) |
| MX (1) | MX2009001553A (es) |
| NO (1) | NO20090410L (es) |
| PE (1) | PE20080607A1 (es) |
| TW (1) | TW200817010A (es) |
| UY (1) | UY30543A1 (es) |
| WO (1) | WO2008020056A2 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US20050255050A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
| US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| ES2530991T3 (es) | 2005-08-15 | 2015-03-09 | Boehringer Ingelheim Int | Procedimiento para la obtención de betamiméticos |
| RU2014109074A (ru) | 2011-08-12 | 2015-09-20 | Бёрингер Ингельхайм Ветмедика Гмбх | ИНГИБИТОРЫ ФАННИ-ТОКА (If), ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ПРИМЕНЕНИЯ В СПОСОБЕ ЛЕЧЕНИЯ И ПРЕДУПРЕЖДЕНИЯ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ У КОШАЧЬИХ |
| WO2014016548A2 (en) | 2012-07-27 | 2014-01-30 | Cipla Limited | Pharmaceutical composition |
| AU2013360692B2 (en) | 2012-12-21 | 2018-08-09 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical formulation comprising ciclesonide |
| SI2934479T1 (sl) | 2012-12-21 | 2019-01-31 | Boehringer Ingelheim Vetmedica Gmbh | Ciklezonid za zdravljenje bolezni dihalnih poti pri konjih |
| WO2014159251A2 (en) | 2013-03-14 | 2014-10-02 | Mayo Foundation For Medical Education And Research | Inhibiting neurotransmitter reuptake |
| PT3157522T (pt) | 2014-06-18 | 2019-12-13 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos e suas combinações para os tratamentos de doenças das vias respiratórias em cavalos |
| EP3359234B1 (de) | 2015-10-09 | 2021-04-28 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung mikrostrukturierter bauteile |
| CN115397417A (zh) * | 2020-04-16 | 2022-11-25 | 广州谷森制药有限公司 | 含有噻托溴铵和奥达特罗的可吸入溶液制剂 |
| WO2021211850A1 (en) * | 2020-04-16 | 2021-10-21 | Anovent Pharmaceutical(U.S.)., Llc | Inhalable formulation of a solution containing olodaterol |
| US20220031712A1 (en) * | 2020-06-23 | 2022-02-03 | Cai Gu Huang | Preparation of a pharmaceutical composition of olodaterol and budesonide |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3134590A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue benzo-heterocyclen |
| KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
| DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| US6960597B2 (en) * | 2000-06-30 | 2005-11-01 | Orth-Mcneil Pharmaceutical, Inc. | Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| WO2005102349A1 (de) * | 2004-04-22 | 2005-11-03 | Boehringer Ingelheim International Gmbh | Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen |
| DE102004024452A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation von Betaagonisten |
-
2007
- 2007-08-15 UY UY30543A patent/UY30543A1/es not_active Application Discontinuation
- 2007-08-16 AU AU2007285746A patent/AU2007285746A1/en not_active Abandoned
- 2007-08-16 CA CA002660480A patent/CA2660480A1/en not_active Abandoned
- 2007-08-16 JP JP2009525029A patent/JP2010501021A/ja active Pending
- 2007-08-16 PE PE2007001103A patent/PE20080607A1/es not_active Application Discontinuation
- 2007-08-16 KR KR1020097005574A patent/KR20090040922A/ko not_active Application Discontinuation
- 2007-08-16 MX MX2009001553A patent/MX2009001553A/es not_active Application Discontinuation
- 2007-08-16 WO PCT/EP2007/058515 patent/WO2008020056A2/de active Application Filing
- 2007-08-16 US US11/839,817 patent/US20080041370A1/en not_active Abandoned
- 2007-08-16 EP EP07819951A patent/EP2054034A2/de not_active Withdrawn
- 2007-08-16 BR BRPI0715692-8A patent/BRPI0715692A2/pt not_active Application Discontinuation
- 2007-08-16 EA EA200900267A patent/EA200900267A1/ru unknown
- 2007-08-17 TW TW096130612A patent/TW200817010A/zh unknown
- 2007-08-17 AR ARP070103672A patent/AR062424A1/es unknown
-
2009
- 2009-01-28 NO NO20090410A patent/NO20090410L/no not_active Application Discontinuation
- 2009-02-12 IL IL197024A patent/IL197024A0/en unknown
- 2009-03-18 CO CO09028166A patent/CO6150123A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2054034A2 (de) | 2009-05-06 |
| CA2660480A1 (en) | 2008-02-21 |
| AR062424A1 (es) | 2008-11-05 |
| AU2007285746A1 (en) | 2008-02-21 |
| WO2008020056A2 (de) | 2008-02-21 |
| EA200900267A1 (ru) | 2009-08-28 |
| UY30543A1 (es) | 2008-03-31 |
| TW200817010A (en) | 2008-04-16 |
| WO2008020056A3 (de) | 2008-09-12 |
| JP2010501021A (ja) | 2010-01-14 |
| KR20090040922A (ko) | 2009-04-27 |
| BRPI0715692A2 (pt) | 2013-08-06 |
| PE20080607A1 (es) | 2008-07-17 |
| NO20090410L (no) | 2009-03-02 |
| US20080041370A1 (en) | 2008-02-21 |
| IL197024A0 (en) | 2009-11-18 |
| MX2009001553A (es) | 2009-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6150123A2 (es) | Formulacion de aerosol que contiene derivados de benzoxazin-3onas | |
| CO6170341A2 (es) | Formulacion de aerosol que contiene derivados de benzoxazin-3onas | |
| AR058082A1 (es) | Formulacion en aerosol para la inhalacion de beta- agonistas | |
| AR049096A1 (es) | Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistas | |
| NO20061833L (no) | Aerosolformulgering for inhalering, inneholdende anticholinergt middel | |
| AR124662A2 (es) | Formulaciones inmunosupresoras | |
| AR070936A1 (es) | 1,2,4 -triazoles trisustituidos | |
| DE602006021539D1 (en) | Morpholine als 5ht2c-agonisten | |
| NO20092723L (no) | Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer | |
| MX2023006047A (es) | Degradadores selectivos del receptor de estrogeno. | |
| WO2008115098A3 (fr) | 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation | |
| MX2012002011A (es) | Composicion farmaceutica que contiene derivado de quinolina. | |
| AR047817A1 (es) | Derivados de aril- y heteroarilpiperidincarboxilatos, su preparacion y su aplicacion en terapeutica | |
| MX2009013626A (es) | DERIVADO DE 17ß-CIANO-18A-HOMO-19-NOR-ANDROST-4-ENO, SU USO Y MEDICAMENTO QUE LO CONTIENE. | |
| AR056873A1 (es) | Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas | |
| AR049650A1 (es) | Derivados 5-aril-1h-pirrol[2,3-b]piridin-3-carboxamida o acido 5-aril-1h-pirrol[2,3-b]piridin-3-carboxilico | |
| BR112012013511A2 (pt) | derivados de difenil-pirazolopiridinas, sua preparação e seu uso como não moduladores do receptor nuclear | |
| NO20070173L (no) | Nye forbindelser | |
| NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
| ATE502936T1 (de) | 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten | |
| NO20065885L (no) | Steroide prolegemidler med androgen virkning | |
| AR062477A1 (es) | Formulacion aerosol para la inhalacion de beta - agonistas | |
| AR065872A1 (es) | Derivados de benzimidazol sustituidos con heterociclos,composiciones farmaceuticas que los contienen,proceso para prepararlos y sus usos en trastornos de ansiedad, trastornos depresivos y enfermedades de alzheimer, entre otros. | |
| NO20081587L (no) | Aerosolformulering for inhalering | |
| AR081965A1 (es) | Derivados aminoester de alcaloides y composicion medicinal de los mismos |